PROGNOSTIC SIGNIFICANCE OF LYMPH NODE RATIO IN RECTAL CANCER AFTER NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY CURATIVE RESECTION.

被引:0
|
作者
Park, J.
Song, M.
Choi, Y.
Kim, J.
Kim, J.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:E188 / E188
页数:1
相关论文
共 50 条
  • [41] yThe Importance of Lymph Node Yield and the Lymph Node Ratio after Neoadjuvant Chemoradiation in Rectal Cancer
    Roy, P.
    Arun, I.
    Mallick, I.
    Banerjee, S.
    Roy, M.
    [J]. CLINICAL ONCOLOGY, 2017, 29 (03) : E79 - E79
  • [42] Risk factors and prognostic significance of lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy for rectal patients with clinically suspected lateral lymph node metastasis
    Zhou, Sicheng
    Jiang, Yujuan
    Pei, Wei
    Liang, Jianwei
    Zhou, Zhixiang
    [J]. BMC SURGERY, 2021, 21 (01)
  • [43] Risk factors and prognostic significance of lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy for rectal patients with clinically suspected lateral lymph node metastasis
    Sicheng Zhou
    Yujuan Jiang
    Wei Pei
    Jianwei Liang
    Zhixiang Zhou
    [J]. BMC Surgery, 21
  • [44] LYMPH NODE RATIO AS A PROGNOSTIC FACTOR IN PATIENTS WITH STAGE III RECTAL CANCER TREATED WITH TOTAL MESORECTAL EXCISION FOLLOWED BY CHEMORADIOTHERAPY
    Kim, Young Seok
    Kim, Jong Hoon
    Yoon, Sang Min
    Choi, Eun Kyung
    Do Ahn, Seung
    Lee, Sang-Wook
    Kim, Jin Cheon
    Yu, Chang Sik
    Kim, Hee Chul
    Kim, Tae Won
    Chang, Heung Moon
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (03): : 796 - 802
  • [45] LYMPH NODE RATIO AS A PROGNOSTIC FACTOR IN PATIENTS WITH STAGE III RECTAL CANCER TREATED WITH TOTAL MESORECTAL EXCISION FOLLOWED BY CHEMORADIOTHERAPY
    Kim, Y. S.
    Kim, J. H.
    Yoon, S. M.
    Choi, E. K.
    Ahn, S. D.
    Lee, S. W.
    Kim, J. C.
    Yu, C. S.
    Kim, T. W.
    Chang, H. M.
    Ryu, M. H.
    Lee, D. H.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S229 - S229
  • [46] Prognostic Significance of the Lymph Node Ratio in Stage IV Colorectal Cancer Patients who have Undergone Curative Resection
    Tsuyoshi Ozawa
    Soichiro Ishihara
    Takeshi Nishikawa
    Toshiaki Tanaka
    Junichiro Tanaka
    Tomomichi Kiyomatsu
    Keisuke Hata
    Kazushige Kawai
    Hiroaki Nozawa
    Takamitsu Kanazawa
    Shinsuke Kazama
    Hironori Yamaguchi
    Eiji Sunami
    Joji Kitayama
    Toshiaki Watanabe
    [J]. Annals of Surgical Oncology, 2015, 22 : 1513 - 1519
  • [47] Prognostic Significance of the Lymph Node Ratio in Stage IV Colorectal Cancer Patients who have Undergone Curative Resection
    Ozawa, Tsuyoshi
    Ishihara, Soichiro
    Nishikawa, Takeshi
    Tanaka, Toshiaki
    Tanaka, Junichiro
    Kiyomatsu, Tomomichi
    Hata, Keisuke
    Kawai, Kazushige
    Nozawa, Hiroaki
    Kanazawa, Takamitsu
    Kazama, Shinsuke
    Yamaguchi, Hironori
    Sunami, Eiji
    Kitayama, Joji
    Watanabe, Toshiaki
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (05) : 1513 - 1519
  • [48] Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
    Tominaga, Tetsuro
    Akiyoshi, Takashi
    Yamamoto, Noriko
    Oba, Koji
    Nagasaki, Toshiya
    Yamaguchi, Tomohiro
    Konishi, Tsuyoshi
    Fukunaga, Yosuke
    Ueno, Masashi
    [J]. SURGERY, 2019, 166 (06) : 1061 - 1067
  • [49] Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer
    Persiani, R.
    Biondi, A.
    Gambacorta, M. A.
    Bertucci Zoccali, M.
    Vecchio, F. M.
    Tufo, A.
    Coco, C.
    Valentini, V.
    Doglietto, G. B.
    D'Ugo, D.
    [J]. BRITISH JOURNAL OF SURGERY, 2014, 101 (02) : 133 - 142
  • [50] The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant Chemotherapy
    Aoyama, Toru
    Yamamoto, Naoto
    Kamiya, Mariko
    Murakawa, Masaaki
    Tamagawa, Hiroshi
    Sawazaki, Sho
    Numata, Masakatsu
    Shiozawa, Manabu
    Kobayashi, Satoshi
    Ueno, Makoto
    Morimoto, Manabu
    Yukawa, Norio
    Oshima, Takashi
    Yoshikawa, Takaki
    Rino, Yasushi
    Masuda, Munetaka
    Morinaga, Soichiro
    [J]. ANTICANCER RESEARCH, 2018, 38 (08) : 4877 - 4882